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Aims: To determine the reproducibility of flow-
mediated dilation (FMD) and nitrate-mediated dilation
(NMD) in the assessment of radial artery vasomotor
function, and to examine the effect of transradial
catheterisation on radial artery injury and recovery.
Methods: Radial artery FMD and NMD were examined
in 20 volunteers and 20 patients on four occasions
(two visits at least 24 hours apart, with two
assessments at each visit). In a further 10 patients,
radial artery FMD was assessed in the catheterised arm
prior to, at 24 hours and 3 months following cardiac
catheterisation.
Results: There were no differences in baseline radial
artery diameter (2.7±0.4 mm vs 2.7±0.4 mm), FMD
(13.4±6.4 vs 12.89±5.5%) or NMD (13.6±3.8% vs
10.1±4.3%) between healthy volunteers and patients
(p>0.05 for all comparisons). Mean differences for
within and between day FMD were 2.53% (95% CIs
−15.5% to 20.5%) and −4.3% (−18.3% to 9.7%) in
patients. Compared to baseline, radial artery FMD was
impaired at 24 hours (8.7±4.1% vs 3.9±2.9%,
p=0.015) but not 3 months (8.7±4.1% vs 6.2±4.4,
p=0.34) following transradial catheterisation.
Conclusions: Radial FMD is impaired early after
transradial catheterisation but appears to recover by
3 months. While test–retest variability was
demonstrated, our findings suggest that transradial
access for cardiac catheterisation may afford a potential
model of vascular injury and repair in vivo in man.
INTRODUCTION
Difﬁculty in translating promising ﬁndings
from preclinical models into the clinic1 is argu-
ably exacerbated by a lack of human in vivo
models to guide translational research and
improve our understanding of human patho-
physiology. An in vivo model to examine vascu-
lar injury and repair would afford mechanistic
insights as well as the opportunity to test novel
therapeutic approaches. While there are
numerous animal models of atherosclerotic
and mechanical injury,2–8 interspecies differ-
ences and imperfect replication of prevailing
clinical conditions limit their direct translation
to humans.
Although rarely resulting in clinically rele-
vant sequelae, transradial catheterisation is
associated with subclinical abnormalities of
radial artery structure9 10 and function11–15
as a consequence of the trauma of intralum-
inal sheath insertion. The routine use of
transradial access in clinical care and the
accessibility of the human radial artery to
non-invasive imaging provide a unique
opportunity to study the mechanisms of vas-
cular injury and repair in vivo in humans.
Flow-mediated dilation (FMD) of the bra-
chial artery is widely established as a tool to
assess vasomotor function in vivo in man.16
While brachial artery FMD is well charac-
terised in terms of reproducibility, radial
KEY QUESTIONS
What is already known about this subject?
▸ Radial artery vasomotor function is impaired fol-
lowing transradial catheterisation. However, the
degree of this dysfunction and the ability of the
artery to regain vasomotor function vary
between studies.
▸ Radial flow-mediated dilation (FMD) is of a
greater magnitude than brachial FMD and there-
fore potentially a more sensitive tool for examin-
ing the effects of cardiovascular risk factors and
therapies. However, it has previously been
shown to be a highly variable technique, limiting
its widespread adoption.
What does this study add?
▸ We quantify the degree of radial FMD variability
within and between days in healthy volunteers
and patients. Transradial catheterisation rapidly
suppresses radial artery function, but this
appears to recover over a 3-month period.
How might this impact on clinical practice?
▸ Transradial catheterisation provides a useful in
vivo clinical model of mechanical arterial injury
and repair. This has major potential for applica-
tion to experimental medicine studies and to
assess the potential benefits of vascular regen-
erative and reparative therapies.
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FMD is not. This may limit its usefulness in this setting
of a potential clinical experimental medicine model of
arterial injury. The aim of this study was to determine
the reproducibility of FMD and nitrate-mediated dilation
(NMD) in the assessment of radial artery function, and
to examine the temporal effect of transradial catheterisa-
tion on radial artery vasomotor function.
METHODS
Participants
Twenty healthy volunteers and 30 patients undergoing
diagnostic transradial cardiac catheterisation for stable
angina were recruited. The project was approved by the
Research Ethics Committee and written informed
consent was obtained from all participants.
Participants were assessed at the same time of day and
asked to avoid food for 4 hours and caffeine, vasoactive
medications, smoking and alcohol for 24 hours prior
study visits. All assessments were carried out in a quiet,
temperature-controlled room and patients rested for
10 min before the ﬁrst study measurements were made.
Study protocols
Protocol 1
A total of 20 healthy volunteers and 20 patients attended
on two occasions at least 24 hours apart. FMD and NMD
of the left radial artery were assessed on two occasions
per visit with at least 1 hour between repeat assessments.
Protocol 2
Ten patients undergoing elective cardiac catheterisation
via the radial artery attended on three occasions (base-
line and 24 hours and 3 months following cardiac cath-
eterisation). FMD and NMD of the radial artery were
assessed in the catheterised (right) arm at each visit.
Flow-mediated and nitrate-mediated dilatation
FMD and NMD were carried out as per international
guidelines.16 17 Brieﬂy, the radial artery was imaged
5 cm proximal to the radial styloid with a 12 MHz linear-
array ultrasound transducer (CX50 Philips Amsterdam,
the Netherlands) held in place by a stereotactic clamp.
A baseline recording was captured over 60 s. A supra-
systolic cuff was then inﬂated to 220 mm Hg for 5 min
immediately distal to the antecubital fossa. Following
release of the cuff, the artery was imaged continuously
for 5 min (FMD). After 15 min of rest, the artery was
once again imaged at rest for 60 s. Participants were
then given 25 µg of sublingual nitrate and the radial
artery imaged for a further 5 min (NMD). This process
was repeated after a 1-hour rest period during which the
participant was disconnected from the equipment and
mobilised.
Systemic haemodynamics
Mean arterial pressure and heart rate were recorded
during the resting period and after cuff release.
Image acquisition
Image acquisition was ECG-gated and arterial diameter
captured during end diastole (R-wave triggered). The
artery was initially identiﬁed using colour ﬂow mapping.
The probe position which gave the largest arterial diam-
eter and clearest deﬁnition of the anterior vessel wall
was chosen to minimise underestimation of lumen diam-
eter. The focus position of the probe was set to the
anterior vessel wall as this is the most challenging to
resolve.16
Image analysis
Images were analysed ofﬂine using proprietary software
(Brachial Analyzer, Vascular Tools, Medical Imaging
Applications, Iowa City, Iowa, USA). Baseline and peak dia-
meters were measured in millimetres with measurements
averaged across 60 frames and 10 frames for baseline and
peak values, respectively. FMD and NMD were expressed
as percentage change in diameter from baseline.
Statistical analysis
Results are reported as mean and SD unless otherwise
stated, reproducibility data are reported as mean bias
with 95% limits of agreement. Comparisons between
groups were made using Student’s t-test. Bland-Altman
plots were used to examine reproducibility using data
obtained from the left radial artery. Comparisons
between time points in protocol 2 were made using
one-way repeated measures analysis of variance
(ANOVA). Statistical analyses were performed using
SPSS V.21.0 (IBM Corp, Armonk, New York, USA).
RESULTS
Participants
All participants (table 1) tolerated the procedures well.
There was no change in mean heart rate or systolic
blood pressure following FMD or NMD.
Flow- and nitrate-mediated dilatation
Arterial diameter
Baseline radial artery diameter was 2.7±0.4 and 2.7
±0.4 mm in the 20 patients and 20 healthy volunteers,
respectively. In cohort 2, there was no change in arterial
diameter following catheterisation with measurements
of 2.8±0.4, 2.83±0.37 and 2.82±0.39 mm at baseline,
24 hours and 3 months, respectively. Repeated measure-
ments of baseline radial artery diameter demonstrated
good reproducibility with intraday coefﬁcient of repeat-
ability (CR) of 0.35 and 0.45 and interday CR of 0.61
and 0.73 in patients and healthy volunteers, respectively.
Dilatation expressed as a percentage of baseline
There were no differences in percentage FMD (13.4±6.4
vs 12.89±5.5%) or NMD (13.7±3.8 vs 10.2±4.4%)
between healthy volunteers and patients, respectively
(ﬁgure 1). There were no differences in the magnitude
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of response for repeat testing within or between days in
either FMD or NMD (p>0.05 for all comparisons).
In healthy volunteers, the mean of the differences for
within-day and between-day measures (bias) was 1.99%
(95% CIs −12.5% to 16.5%) and 3.2% (95% CI −13.8%
to 7.5%), respectively, for FMD and 1.8% (95% CI
−12.0% to 15.7%) and 1.7% (95% CI −8.7% to 12.1%),
respectively, for NMD. In patients, the mean of the dif-
ferences for within-day and between-day measures was
2.53% (95% CI −15.5% to 20.5%) and −4.3% (95% CI
−18.3% to 9.7%), respectively, for FMD and 0.7% (95%
CI −12.1% to 13.6%) and 1.7% (95% CI −13.9% to
17.3%), respectively, for NMD (ﬁgures 2 and 3).
Dilatation as absolute change in vessel diameter (mm)
There were no differences in absolute FMD (0.3±0.3 vs
0.2.±0.2 mm) or NMD (0.3±0.3 vs 0.2±0.2 mm) between
healthy volunteers and patients, respectively. For FMD
and NMD, there were no differences in the magnitude
of responses for repeat testing within or between days
(p>0.05 for all comparisons).
In healthy volunteers, the mean of the differences for
within-day and between-day measures (bias) was −0.01 mm
(95% CI −0.32 to 0.38 mm) and 0.03 mm (95% CI −0.3 to
0.31 mm), respectively, for FMD and 0.02 mm (95% CI
−0.30 to 0.33 mm) and 0.03 mm (95% CI 0.35 to
0.38 mm), respectively, for NMD. In patients, the mean of
the differences for within-day and between-day measures
was 0.01 mm (95% CI −0.3 to 0.35 mm) and −0.02 mm
(−0.35 to 0.38 mm), respectively, for FMD and 0.03 mm
(95% CI −0.35 to 0.40 mm) and 0.02 mm (95% CI −0.30
to 0.35 mm), respectively, for NMD (ﬁgures 4 and 5).
Arterial function following catheterisation (cohort 2)
In the 10 patients undergoing cardiac catheterisation,
baseline radial diameter was 2.8±0.5 mm (table 1).
Compared with baseline, radial artery FMD was impaired
at 24 hours (8.6±4.0% vs 3.9±2.9%, p=0.015) but not at
3 months (8.6±4.0% vs 6.2±4.4%, p=0.34; ﬁgure 6) fol-
lowing transradial catheterisation.
As with FMD, compared with baseline NMD was
impaired at 24 hours (8.7±5.5% vs 2.8±2.5%, p=0.006).
Response to nitrates remained impaired at 3 months
(8.7±5.5% vs 4.8±2.7%, p=0.047; ﬁgure 6) following
transradial catheterisation.
DISCUSSION
We have here demonstrated that FMD and NMD can be
used to assess radial artery vasomotor function in man
Table 1 Baseline characteristics of study populations







Age 61±9 22±4 69±9
Female (%) 15 (75) 13 (65) 3 (30)
Heart rate 62±10 70±12 64±9
Systolic blood pressure 138±12 118±9 135±17
Smoker (%) 4 (20) 0 (0) 3 (30)
Coronary artery disease (%) 18 (90) 0 (0) 7 (70)
Diabetes (%) 4 (20) 0 (0) 2 (20)
Hypertension (%) 15 (75) 0 (0) 90 (90)
Hyperlipidaemia 15 (75) 0 (0) 70 (70)
Statin 20 (100) – 9 (90)
Aspirin 19 (95) – 10 (100)
β-Blocker 12 (60) – 6 (60)
Nitrate 6 (30) – 4 (40)
Calcium channel blocker 8 (40) – 5 (50)




Figure 1 Baseline flow and nitrate mediated dilation in
patients and healthy controls. Baseline flow-mediated dilation
(FMD) response in healthy volunteers shows no difference
from that seen in patients (13.4±6.4 vs 12.9±5.5%, p=0.68).
Baseline nitrate-mediated dilation (NMD) response was also
similar in healthy volunteers and patients (13.7±3.8% vs 10.2
±4.4, respectively, p=0.18).
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with acceptable reproducibility. Using this technique, we
have demonstrated that radial artery vasomotor function
is impaired early after transradial access for cardiac cath-
eterisation, but appears to recover, at least in part, by
3 months with endothelium-dependent vasodilatation no
longer signiﬁcantly different from baseline. While
impairment of radial function postcatheterisation has
previously been described, reproducibility of this tech-
nique is not well characterised; adding to the work of
Brook et al18 who characterised reproducibility in
Figure 2 Reproducibility in percentage flow-mediated dilation. Within-day (A and C) and between-day (B and D) variability in
healthy volunteer patients. The continuous grey line represents the mean of the differences of the two measurements (the mean
bias) and the red lines represent the 95% CIs (limits of agreement).
Figure 3 Reproducibility in percentage nitrate-mediated dilation. Within-day (A and C) and between-day (B and D) variability in
healthy volunteer patients. The continuous grey line represents the mean of the differences of the two measurements (the mean
bias) and the red lines represent the 95% CIs (limits of agreement).
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healthy volunteers, we have also made an assessment in
a patient cohort. Our ﬁndings suggest that transradial
access for cardiac catheterisation may afford a potential
model of vascular injury and repair in vivo in man.
Previous studies have demonstrated that the hetero-
geneity observed in the FMD response is dependent in
part on the ﬂow stimulus19 20 as well as underlying phys-
ical characteristics of participants.19 To address these
potential concerns, we standardised the environmental
conditions and experimental protocol, although we did
not document the ﬂow stimulus by Doppler ultrasound.
We observed minimal within-day and between-day
Figure 4 Reproducibility in absolute flow-mediated dilation. Within-day (A and C) and between-day (B and D) variability in
healthy volunteer patients. The continuous grey line represents the mean of the differences of the two measurements (the mean
bias) and the red lines represent the 95% CIs (limits of agreement).
Figure 5 Variability in absolute nitrate-mediated dilation. Within-day (A and C) and between-day (B and D) variability in healthy
volunteer patients. The continuous grey line represents the mean of the differences of the two measurements (the mean bias)
and the red lines represent the 95% CIs (limits of agreement).
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variability in the measurement of absolute radial artery
diameter using ultrasound. However, we did observe
more prominent heterogeneity in the relative responses
to FMD and NMD in healthy volunteers and patients.
The variability in radial FMD is more pronounced
than the more widely used brachial FMD, for which a
coefﬁcient of variation of 1.8% has previously been
reported in the original study by Sorensen et al.21
However, the calculation of this variability was unclear,
and while subsequent studies have reported that base-
line brachial artery diameter can be measured reprodu-
cibly, most report a coefﬁcient of variation for brachial
FMD of between 10% and 50%.22–25
Although the resting diameter of the radial artery is
smaller than the brachial artery, vasodilatation causes
similar the absolute increases in arterial diameter with
both arteries. This has some important effects on the
calculation of the relative diameter changes for FMD
and NMD. In other words, the percentage change in
vessel size is larger for radial than brachial FMD because
of the smaller denominator. While superﬁcially this is
attractive for the detection of changes due to thera-
peutic interventions, inaccuracies will be exaggerated
and reproducibility compromised. The lack of linearity
between baseline diameter and absolute FMD response
has been suggested as a confounder in comparisons
between and within participants. Atkinson et al26 suggest
a promising way of correcting for this, although this is
yet to be widely adopted. Ultimately our data demon-
strate that absolute and relative changes in radial FMD
and NMD are more variable than those seen for the bra-
chial artery and this is consistent with previous work.18
Dilation of the radial artery in the human forearm in
response to short periods of ischaemia is dependent on an
intact endothelium and is attenuated by infusion of
the nitric oxide synthase inhibitor, NGmonomethyl-L-
arginine.19 Acute disruption of the vessel wall has been
demonstrated following transradial cardiac catheterisation
using optical coherence tomography-based intravascular
imaging.9 10 The catheterised radial artery has also been
examined histologically at the time of conduit harvest for
coronary artery bypass grafting with one study demonstrat-
ing endothelial disruption, with the degree of endothelial
loss inversely related to the time since catheterisation,27
although this has not been a universal ﬁnding.28 It is per-
haps not surprising therefore that we and others12–14 29–31
have demonstrated that transradial catheterisation results
in impairment of FMD of the radial artery. This likely
represents endothelial denudation with recovery of vaso-
motor function indicating reconstitution of the monolayer.
The attenuation of FMD and NMD after radial catheterisa-
tion is in keeping with previous studies13 14 and implies
that the vascular injury involves the vascular smooth
muscle layer and the superﬁcial endothelial layer. The
time course of recovery remains unclear with some
authors reporting complete recovery of radial artery vaso-
motor function,11 29 32 while others observed irreversible
impairment.14 Our data would suggest that there is some
recovery of function at 3 months, but we cannot be conﬁ-
dent of complete restoration of function.
Previous studies have used the radial artery in the
context of cardiac catheterisation to examine the inﬂu-
ence of factors such as sheath coating13 and drug
therapy2 31 33 on endothelial recovery. These models
have however only examined forearm vasomotion and at
a limited number of time points—a limitation shared by
our study. Understanding the exact mechanism, the
time course of injury and its recovery is critical if this
model is to realise its potential in the study of vascular
injury and repair in vivo in man.
It is important to highlight a number of limitations of
our study. In addition to the modest sample size and
innate heterogeneity observed in forearm vasomotor
responses, it would be helpful to include the contralat-
eral arm as control in any future studies examining this
model in more detail. While our protocol was
Figure 6 Flow-mediated and nitrate-mediated dilation in
following radial artery catheterisation. Flow-mediated dilation
(FMD) in the catheterised right radial artery is impaired at
24 hours (3.9±2.9%) when compared to baseline (8.6±4.0%,
p=0.015). There was some degree of functional recovery by
3 months (6.2±4.4%) by which time FMD was not significantly
different to baseline (p=0.34). Nitrate-mediated dilation
(NMD) was similarly impaired at 24 hours (2.8±2.5%) when
compared to baseline (9.4±5.1%, p=0.006). Again, there was
some improvement by 3 months (4.8±2.7%) but this had not
returned to baseline (p=0.047).
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standardised to minimise variation in hyperaemic stimu-
lus, we did not quantitatively assess radial blood ﬂow vel-
ocity, variations in which may have affected the
vasodilator response. We also did not attempt to charac-
terise the extent or mechanism of injury inﬂicted on the
radial artery at the time of catheterisation. This could
have been achieved with intravascular imaging modal-
ities such as intravascular ultrasound or optical coher-
ence tomography. Further work, combining
intravascular imaging with cellular and cytokine proﬁl-
ing, would deﬁne this in greater detail and improve our
understanding of this promising model of in vivo arterial
injury in man.
CONCLUSION
While radial FMD is a technique with inherent variabil-
ity, the larger magnitude of baseline response than bra-
chial FMD and the profound impact of catheterisation
on endothelial function mean that the effect of arterial
injury can be demonstrated in a small cohort of patients.
Combined with the ubiquitous use of radial access and
the non-invasive nature of FMD, this makes transradial
cardiac catheterisation a powerful and accessible tool for
studying mechanical vascular injury. We believe that this
model will permit mechanistic insights into the pro-
cesses of vascular injury and repair as well as the modify-
ing inﬂuences of cardiovascular risk factors and
therapies.
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